40MO 子宫内膜癌(EC)的一线(1L)durvalumab+卡铂/紫杉醇(CP)，然后是durvalumab±奥拉帕利(DUO-E)：按错配修复（MMR）状态分列的客观应答率（ORR）、应答持续时间（DoR）和治疗中断或死亡时间（TDT）

{"title":"40MO 子宫内膜癌(EC)的一线(1L)durvalumab+卡铂/紫杉醇(CP)，然后是durvalumab±奥拉帕利(DUO-E)：按错配修复（MMR）状态分列的客观应答率（ORR）、应答持续时间（DoR）和治疗中断或死亡时间（TDT）","authors":"E. Van Nieuwenhuysen , H.S. Chon , J. Thomes Pepin , M. Sundborg , M. Gold , B-G. Kim , S.V. Blank , J. Liu , M. McCollum , M. Mori , K.N. Moore , C. Joseph de Pádua , J. Martinez-Garcia , C. Papadimitriou , K. Grisan , R.L. Póka , C. Donnelly , X. Liu , S. Westin","doi":"10.1016/j.esmoop.2024.103540","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":11877,"journal":{"name":"ESMO Open","volume":null,"pages":null},"PeriodicalIF":7.1000,"publicationDate":"2024-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2059702924013097/pdfft?md5=2a0e1522221226c4a46f3fde946c1363&pid=1-s2.0-S2059702924013097-main.pdf","citationCount":"0","resultStr":"{\"title\":\"40MO First-line (1L) durvalumab + carboplatin/paclitaxel (CP) followed by durvalumab ± olaparib for endometrial cancer (EC) (DUO-E): Objective response rate (ORR), duration of response (DoR) and time to treatment discontinuation or death (TDT) by mismatch repair (MMR) status\",\"authors\":\"E. Van Nieuwenhuysen , H.S. Chon , J. Thomes Pepin , M. Sundborg , M. Gold , B-G. Kim , S.V. Blank , J. Liu , M. McCollum , M. Mori , K.N. Moore , C. Joseph de Pádua , J. Martinez-Garcia , C. Papadimitriou , K. Grisan , R.L. Póka , C. Donnelly , X. Liu , S. Westin\",\"doi\":\"10.1016/j.esmoop.2024.103540\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":11877,\"journal\":{\"name\":\"ESMO Open\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":7.1000,\"publicationDate\":\"2024-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.sciencedirect.com/science/article/pii/S2059702924013097/pdfft?md5=2a0e1522221226c4a46f3fde946c1363&pid=1-s2.0-S2059702924013097-main.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"ESMO Open\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S2059702924013097\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"ESMO Open","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2059702924013097","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}